[Pharmacogenomic and pharmacometabolomic biomarkers of the efficacy and safety of antidepressants: focus on selective serotonin reuptake inhibitors].

Autor: Gareeva AE; Institute of Biochemistry and Genetics of the Ufa Federal Research Center of the Russian Academy of Sciences, Ufa, Russia.; Kemerovo State University, Kemerovo, Russia.; Russian Medical Academy of Continuing Professional Education, Moscow, Russia., Borodina LS; Republican Narcological Dispensary No. 1, Ufa, Russia., Pozdnyakov SA; Moscow Scientific and Practical Center for Narcology of the Moscow Health Department, Moscow, Russia., Timerbulatov IF; Russian Medical Academy of Continuing Professional Education, Moscow, Russia.; Usoltsev Central Clinical Psychiatric Hospital, Moscow, Russia.; Russian University of Medicine, Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2024; Vol. 124 (6), pp. 26-35.